Wednesday, December 5, 2012

Femtosecond laser surgery continues to advance

Laura Harris
Since the turn of the 21st century, the femtosecond laser has been gaining momentum in the field of laser surgery. Its high peak intensity and short pulse duration result in an energy-conscious ablation tool that negligibly heats its surroundings. It is widely versatile, and from its debut in LASIK procedures by IntraLase to its role in nerve regeneration studies, plasmonic nanosurgery, endoscopic advancements, and cellular nanoprocessing, the utility of the femtosecond laser is just beginning.1-8

The Ben-Yakar Laboratory at The University of Texas at Austin is advancing femtosecond laser technologies through a number of novel approaches. Our cutting-edge research of nerve regeneration in C. elegans could lead to advanced understanding of traumatic nerve injuries and degenerative diseases such as Alzheimer’s disease.2-3 Our breakthroughs in plasmonic laser nanoablation could ultimately impact both cellular and material nanoprocessing.4-5 Our development of a microsurgical endoscope could lead to a next-generation clinical surgery scalpel, with unprecedented clinical applications that require miniaturization and flexible laser delivery through fibers.6-8

Now, we are turning our attention to yet another area in which femtosecond lasers can shine. In recent years, the femtosecond laser has been utilized in tissue engineering and live cell processing. We intend to combine our microfluidic and femtosecond laser specialties in order to delve into the realm of cell signaling and gene transfection in mouse embryonic stem cells. The femtosecond laser is becoming an efficient tool for cell membrane optoporation, and in this new project, we will ultimately create a lab-on-chip operated in conjunction with femtosecond laser optoporation in order to investigate the role of Fgf signaling in stem cell fate decisions. The obvious potential of the femtosecond laser is growing, and the Ben-Yakar Laboratory is turning potential into reality.


REFERENCES
1. I. E. Ratkay-Traub, T. Ferincz, R. M. Juhasz, R. M. Kurtz, and R. R. Krueger, J. Refract. Surg., 19, 94–103 (2003).
2. S. X. Guo et al., Nat. Meth., 5, 6, 531–533 (2008).
3. F. Yanik et al, Nature, 432, 822 (2004).
4. A. Ben-Yakar, D. Eversole, and S. X. Guo, "Plasmonic laser nanoablation," US Patent 7834331, issued 11/16/2010.
5. D. S. Eversole, B. Luk’yanchuk, and A. Ben-Yakar, Appl. Phys. A, 89, 283–291 (2007).
6. C. L. Hoy et al., Opt. Exp., 19, 10536–10552 (2011).
7. C. L. Hoy, W. N. Everett, J. Kobler, and A. Ben-Yakar, "Towards endoscopic ultrafast laser microsurgery of vocal folds," Proc. SPIE,  7548, 754831 (2010).
8. C. L. Hoy et al., Opt. Exp., 16, 13, 9996–10005 (2008).


LAURA HARRIS is a graduate research assistant in the Ben-Yakar Laboratory at the University of Texas at Austin, which focuses on femtosecond laser-assisted biophotonics. Her work integrates femtosecond laser nanosurgery and microfluidic techniques to investigate the fate choice of mouse embryonic stem cells.


Students! Professors! Want your work represented in BioOptics World StudentView? Contact us for guidelines: leem@pennwell.com, barbarag@pennwell.com.

Friday, November 16, 2012

Optical treatment planning for interstitial photodynamic therapy

Tim Baran

A number of research groups, including Thomas Foster’s lab at the University of Rochester, have become interested in using photodynamic therapy (PDT) to treat cancers that are located deep within the body.

PDT is an emerging cancer therapy that uses a combination of light-sensitive drugs, known as photosensitizers, and targeted illumination to create photochemical reactions that result in the destruction of cancer cells. Since the treated area is limited by the penetration depth of the treatment light, PDT has typically been used to treat superficial malignancies of the skin and other easily accessible regions.   

To make it work within the body, the photosensitizer is delivered systemically or locally, and allowed to accumulate in the tumor. Under image guidance, cylindrical diffusing fibers are then inserted into the tumor to deliver the treatment light. This treatment light is usually delivered by a laser with wavelengths varying from 630-700 nm (and beyond), depending on the photosensitizer used. As the diffusers used can be as long as 5 cm for large tumors, the required laser power at the source can approach or exceed 1 W.

As interstitial PDT is often performed in regions where there is sensitive healthy tissue nearby, there is a need for careful treatment planning. Towards that end, we have developed a Monte Carlo simulation space that allows for patient optical properties and anatomy to be incorporated into a rigorous treatment plan. 

Unlike radiation therapy, in which radiation doses can be directly computed from CT scan data, calculations of optical dose require knowledge of the patient’s optical properties, which can vary among patients and even within a single patient. Therefore, spectroscopic determination of optical properties is required before a treatment plan can be formulated.
Simulated patient data showing the insertion of four cylindrical diffusing fibers for photodynamic therapy of head and neck cancers
A number of techniques exist to do this. In our case, we use a custom optical probe that is inserted into the treatment region and a Monte Carlo based fitting algorithm in order to extract optical properties. These extracted optical properties are then combined with CT image data from the patient in order to build an optical and anatomical map of the patient in our simulation space. The number of diffusers, and the amount of light delivered by them, can then be optimized using a constrained nonlinear optimization algorithm. This ensures that tumor tissues receive a physician-prescribed light dose, while damage to healthy tissue is minimized.

My work thus far has been preclinical, using simulated data sets and animal models. We are actively seeking to translate interstitial PDT into the clinic at the University of Rochester Medical Center for treatment of cholangiocarcinoma, cancers of the head and neck, and deep-tissue microbial infections.

TIM BARAN is a PhD candidate in the Institute of Optics at the University of Rochester (Rochester, NY).  His research in the Foster lab is related to optical dosimetry and treatment planning for interstitial photodynamic therapy, with an emphasis on the simulation of light propagation in tissue.

Students! Professors! Want your work represented in BioOptics World StudentView? Contact us for guidelines: leem@pennwell.com, barbarag@pennwell.com.

Thursday, October 4, 2012

Student researchers discuss biomedical optics' progress and impact

Kellie Chadwick    

Welcome to the BioOptics StudentView blog. Here, you will find posts written by university students studying biomedical optics and photonics and their applications. You will hear about their research and utilization of optical technologies in their studies; that is, advances in both biophotonics tools and the life sciences work they enable.

In a field with technology that continues to rapidly develop, students must remain ahead of the curve. As an intern at BioOptics World  and a student studying biomedical engineering, I've found that as technology continues to progress, developers continue to create devices that are smaller (such as this portable flow cytometer), have higher resolution (like this 29 Megapixel camera), better accuracy and reliability, are more cost-effective, more durable, and sustainable. All of this adds up to more power and flexibility in the hands of researchers.

This blog aims to share the advances and creativity of current students and scholastic laboratories, while looking to the future of biomedical optics and photonics technology. The BioOptics World staff hopes that you enjoy the perspectives offered by students who represent the future of this field!

KELLIE CHADWICK is a senior at Worcester Polytechnic Institute (WPI; Worcester, MA) majoring in biomedical engineering, with a concentration in biomaterials and tissue engineering--the latter of which garnered her interest because of various research possibilities and the advancements in medicine. Her senior year capstone project is to design a biomorphic tissue scaffold that can be fabricated with an inexpensive 3D printer.

Students! Professors! Want your work represented in BioOptics World StudentView? Contact us for guidelines: leem@pennwell.com, barbarag@pennwell.com.